Generation Bio stockholders approve reverse stock split (1:10 to 1:30) at 2025 annual meeting

Generation Bio Co.

Reverse stock split authorized at ratio 1-for-10 to 1-for-30; board has sole discretion on exact ratio and timing.
Ron Cooper, Anthony Quinn, and Jason Rhodes elected as Class II directors, each to serve until 2028.
Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2025.
Advisory vote on executive compensation approved: ~38.1M for, ~360K against, ~22K abstentions.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.